Complete tumor regression was observed in two of these three patients.

"We are reporting that five patients who received the antibody went on to tumor regression that was at least 30% or more," he says.

DCA was associated with tumor regression and had a good safety profile.

This was due, in part, to spontaneous tumor regression.

Some degree of spontaneous tumor regression occurred in nearly half the infants.

Restoration of p53 function leads to tumor regression in vivo.

He said 9 of the 22 showed positive results, including 2 who "showed complete tumor regression."

A complete response was reported for one patient, and partial tumor regression was observed in eight patients.

We haven't seen significant tumor regression with anyone.

Even if it were the protocol, tumor regression would be gradual.